Table 3.

Comparison of clinical characteristics and plasma CFH level between baseline and endpoint (12th week) in group with anhedonia.

	Baseline	Endpoint	Change	Z	P
PANSS positive subscores	21.09 ± 4.08	15.23 ± 2.06	−7.73 ± 2.83	−6.96	<0.01
PANSS negative subscores	27.86 ± 2.61	18.14 ± 4.05	−9.72 ± 4.99	−7.81	<0.01
PANSS general subscores	33.78 ± 2.51	23.72 ± 3.31	−10.07 ± 4.18	−7.43	<0.01
PANSS total score	82.74 ± 5.57	57.08 ± 5.58	−27.53 ± 7.23	−7.47	<0.01
SHAPS	10.00 ± 2.27	7.65 ± 2.16	−2.35 ± 3.39	−4.90	<0.01
CFH (AU/mL)	435.01 ± 75.32	401.71 ± 95.65	−33.29 ± 115.28	−2.40	0.017